September 27, 2024 - 12:00 - 1:00 p.m. - Livestream Webinar - Broadcast in Central Time

In this webinar, participants explore the management of adverse drug reactions in tuberculosis (TB) treatment. This session features three distinguished experts—a physician, a pharmacist, and a nurse—each providing unique perspectives on the progression of care for patients undergoing TB treatment.

November 8, 2024 - Renaissance St. Louis Airport Hotel - St. Louis, Missouri

The Bi-State Infectious Disease Conference was developed in 1996 as a collaborative effort of the local APIC Chapter 73, public health departments and school nurses in the Missouri and Illinois bi-state area. The annual conference is designed to provide continuing education for healthcare professionals from Missouri and Illinois. It provides the most current information for disease intervention, detection, prevention, control and preparedness pertaining to infectious disease in order to provide optimal healthcare to our patients and to our community.

Online Course Through MyLearning

This course is for Mayo Clinic Personnel only

In this module you will learn about the impact of discussing sexual orientation and gender identity in patients with serious illness.

April 3 - 5, 2025 - One Ocean Resort & Spa - Atlantic Beach, Florida

This course offers Live (in-person) and Livestream (virtual) attendance options

Mayo Clinic’s Critical Care Review for the Nurse Practitioner and Physician Assistant is an interactive course designed for advanced practice providers working with critically ill adult patients. The course is comprised of lecture-based sessions covering essential acute care topics such as vasoactive support, ECMO, secondary trauma assessment, intracranial pressure, anticoagulant reversal, acute liver failure, toxicology, and more.

September 20, 2024 - Webinar - Broadcast in Central Time

This session focuses on the essential aspects of TB management, highlighting the importance of partnering with Public Health. Participants will review key principles in pulmonary and extrapulmonary TB management, primary treatment regimens for drug-susceptible and drug-resistant TB, and the conditions necessary to start combination drug therapy. This session equips healthcare providers with practical knowledge to enhance TB patient outcomes.

September 25, 2024 - Webinar - Broadcast in Central Time

Latent Tuberculosis Infection (LTBI) is a significant public health concern due to its potential to progress to active TB if untreated. This session will provide healthcare providers with essential knowledge on LTBI, including distinguishing it from active TB, accurately diagnosing it using TST and IGRAs and treating it with current regimens. The session will also explore strategies for effectively managing LTBI patients, emphasizing patient education, adherence, and collaboration with public health resources, ensuring that any healthcare provider can confidently manage LTBI cases.

September 13, 2024 - Webinar - Broadcast in Central Time

This session will delve into the distinct characteristics of tuberculosis (TB) in children compared to adults. Participants will examine variations in TB occurrence, risk factors, and how the disease manifests in young patients. The session will also address the differences in diagnosing TB in children, including interpreting chest X-rays and utilizing tests like IGRAs. Finally, the discussion will focus on the unique factors to consider when treating TB in children, covering both latent infection and active disease.